0.00Open0.05Pre Close0 Volume44 Open Interest15.00Strike Price0.00Turnover5183.11%IV20.11%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0862Delta0.1196Gamma250.60Leverage Ratio-72.3555Theta0.0000Rho21.59Eff Leverage0.0000Vega
Stoke Therapeutics Stock Discussion
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet